Abstract: Methods and apparatuses for setting a therapeutic dose of a neuromodulator implanted into a patient. The therapeutic dose typically includes a therapeutic dose duration including a ramp-up time to reach a peak modulation voltage and a sustained peak modulation time during which the voltage is sustained at the peak modulation voltage. The methods and apparatuses may use a testing ramp to identify a peak modulation voltage that is patient-specific and provides a maximized therapeutic effect while remaining comfortably tolerable by the patient during the application of energy by the neuromodulator.

Abstract: A bulk capacitor assembly for an inverter includes a stacked busbar, the stacked busbar including a first direct current (DC) busbar and a second DC busbar; one or more first capacitors on a first side of the stacked busbar, the one or more first capacitors electrically connected to the first DC busbar and the second DC busbar; and one or more second capacitors on a second side of the stacked busbar, the first side being opposite to the second side, the one or more second capacitors electrically connected to the first DC busbar and the second DC busbar.

Abstract: A system for an electric vehicle includes: an inverter housing including an inner wall, a first channel, and an exterior surface; and a heatsink coupled to the exterior surface of the inverter housing, the heatsink including a second channel; wherein the first channel in the inverter housing and the second channel in the heatsink define a cooling circuit, and wherein the first channel is fluidly connected to the second channel to pass a coolant through the cooling circuit.

Abstract: Methods and apparatuses for setting a therapeutic dose of a neuromodulator implanted into a patient. The therapeutic dose typically includes a therapeutic dose duration including a ramp-up time to reach a peak modulation voltage and a sustained peak modulation time during which the voltage is sustained at the peak modulation voltage. The methods and apparatuses may use a testing ramp to identify a peak modulation voltage that is patient-specific and provides a maximized therapeutic effect while remaining comfortably tolerable by the patient during the application of energy by the neuromodulator.

Abstract: At least some embodiments of present disclosure direct to a fuel injection timing drift detection and/or compensation system. In some cases, the system collects or receives a series of fuel pressure data measured by one or more fuel pressure sensors. The system is configured to receive an indication of fuel flow cutout and a start-of-injection command signal. The system calculates a set of pressure drops using the series of fuel pressure data and identifies a selected pressure drop greater than a predetermined threshold to determine a measured start-of-injection timing based on the selected pressure drop. The system is further configured to evaluate whether a fuel injection drifting occurs based on received start-of-injection command signal and the measured start-of-injection timing. In some cases, the fuel injection drifting is used to either compensate fuel injection timing or raise a flag indicating the drifting.

Abstract: A durable nerve cuff electrode for achieving block of an action potential in a large diameter nerve.

Abstract: A system to generate power, the system comprising a shaft configured for one-directional rotation around a horizontal axis, an inertial object coupled to the shaft where the inertial object has an uneven distribution of mass around the shaft, an electric generator configured to extract rotational kinetic energy from the shaft, and an electric motor configured to provide restorative energy to the shaft. The power generation method comprises steps of providing a power generation system, placing the shaft in an initial position, and inducing shaft rotation. Once shaft rotation is induced, the method alternates between steps of power generation and power consumption. More power is generated than consumed, resulting in a surplus of power supplied to the grid.

Abstract: At least some embodiments of present disclosure direct to a fuel injection timing drift detection and/or compensation system. In some cases, the system collects or receives a series of fuel pressure data measured by one or more fuel pressure sensors. The system is configured to receive an indication of fuel flow cutout and a start-of-injection command signal. The system calculates a set of pressure drops using the series of fuel pressure data and identifies a selected pressure drop greater than a predetermined threshold to determine a measured start-of-injection timing based on the selected pressure drop. The system is further configured to evaluate whether a fuel injection drifting occurs based on received start-of-injection command signal and the measured start-of-injection timing. In some cases, the fuel injection drifting is used to either compensate fuel injection timing or raise a flag indicating the drifting.

Abstract: A durable nerve cuff electrode for achieving block of an action potential in a large diameter nerve.

Abstract: Methods and apparatuses for collecting and quantifying patient-reported data from a neuromodulator. The patient-reported data typically includes a pain score that quantifies the level of pain experienced by the patient at a particular time. The apparatus can include a user interface that allows the patient to enter such information in real time. The methods and apparatuses can include a correlation process, whereby each patient-reported entry is correlated with a corresponding neuromodulation treatment. This correlation can be used to identify treatment parameters and dosages that are most effective, and to further identify when certain dosages are most effective. This information can further be used as feedback to generate optimized treatments for a specific patient and iteratively improve the treatments. In some cases, the correlation process identifies under reported or over reported data, which can be filtered out to provide more accurate optimized treatments.

Abstract: Methods and apparatuses for setting a therapeutic dose of a neuromodulator implanted into a patient. The therapeutic dose typically includes a therapeutic dose duration including a ramp-up time to reach a peak modulation voltage and a sustained peak modulation time during which the voltage is sustained at the peak modulation voltage. The methods and apparatuses may use a testing ramp to identify a peak modulation voltage that is patient-specific and provides a maximized therapeutic effect while remaining comfortably tolerable by the patient during the application of energy by the neuromodulator.

Abstract: Methods and apparatuses for setting a therapeutic dose of a neuromodulator implanted into a patient. The therapeutic dose typically includes a therapeutic dose duration including a ramp-up time to reach a peak modulation voltage and a sustained peak modulation time during which the voltage is sustained at the peak modulation voltage. The methods and apparatuses may use a testing ramp to identify a peak modulation voltage that is patient-specific and provides a maximized therapeutic effect while remaining comfortably tolerable by the patient during the application of energy by the neuromodulator.

Abstract: A durable nerve cuff electrode for achieving block of an action potential in a large diameter nerve.

Abstract: A durable nerve cuff electrode for achieving block of an action potential in a large diameter nerve.

Abstract: Methods and apparatuses for setting a therapeutic dose of a neuromodulator implanted into a patient are described. The therapeutic dose typically includes a therapeutic dose duration including a ramp-up time to reach a peak modulation voltage and a sustained peak modulation time during which the voltage is sustained at the peak modulation voltage. The methods and apparatuses described herein may use a testing ramp to identify a peak modulation voltage that is patient-specific and provides a maximized therapeutic effect while remaining comfortably tolerable by the patient during the application of energy by the neuromodulator.

Abstract: An adhesively attached eye mask includes a transparent or semi-transparent plastic eyepiece for positioning over a user's eyes and an integral elongated transparent plastic temple or tab extending rearward from each side edge of the eyepiece for contacting the sides of a user's face. A peripheral edge of the eyepiece can include an adhesive. A face mask can be connected to a lower edge of the eye mask for covering the user's nose and mouth. A peripheral edge of the face mask can include an adhesive. A flexible loop or band can be positioned at each side of the face mask.

Abstract: Methods and apparatuses for setting a therapeutic dose of a neuromodulator implanted into a patient are described. The therapeutic dose typically includes a therapeutic dose duration including a ramp-up time to reach a peak modulation voltage and a sustained peak modulation time during which the voltage is sustained at the peak modulation voltage. The methods and apparatuses described herein may use a testing ramp to identify a peak modulation voltage that is patient-specific and provides a maximized therapeutic effect while remaining comfortably tolerable by the patient during the application of energy by the neuromodulator.

Abstract: Methods and systems, using a controller (20), for performing fuel pressure control operation of an engine (12) having at least one cylinder (16) is disclosed. The controller (20) includes a fuel system control unit (42) configured to control a fuel pressure applied to at least one injector (18) of the engine (12) during a motoring condition period (412) based on a commanded pulse train duration (410). During the motoring condition period (412), no combustion occurs in the at least one cylinder (16) of the engine (12). The commanded pulse train duration is a time period during which the at least one injector (18) of the engine (12) is activated for a drain operation. The fuel system control unit (42) is configured to command the at least one injector (18), for the commanded pulse train duration during the motoring condition period (412), to release fuel from the at least one injector (18) without injecting the fuel into the at least one cylinder (16) of the engine (12).

Abstract: An information handling system may include a processor and a basic input/output system comprising a program of instructions executable by the processor and configured to cause the processor to determine if a captured stop error code captured in connection with an operating system stop error occurring during a previous boot session of the information exists on a memory accessible to the basic input/output system and responsive to the captured stop error code existing on the memory, read the captured stop error code and perform a remedial action based on the captured stop error code.

Abstract: Methods and apparatuses for collecting and quantifying patient-reported data from a neuromodulator. The patient-reported data typically includes a pain score that quantifies the level of pain experienced by the patient at a particular time. The apparatus can include a user interface that allows the patient to enter such information in real time. The methods and apparatuses can include a correlation process, whereby each patient-reported entry is correlated with a corresponding neuromodulation treatment. This correlation can be used to identify treatment parameters and dosages that are most effective, and to further identify when certain dosages are most effective. This information can further be used as feedback to generate optimized treatments for a specific patient and iteratively improve the treatments. In some cases, the correlation process identifies under reported or over reported data, which can be filtered out to provide more accurate optimized treatments.